Strainsforpains, Inc. announces shareholder updates and milestones met.

Strainsforpains, Inc. Announces Corporate Update on its JV relationships and it's facility. End Quote

New York, NY (1888PressRelease) January 24, 2024 - Strainsforpains, Inc. Announces Corporate Update (NY, NY)-(January 24, 2024)(Strainsforpains, Inc.) (OTC Markets : EBYH).

Strainsforpains, Inc. (OTC Markets:EBYH), a New York-based purveyor of enterprise-class technology solutions for the cannabis and pain management industry has successfully renewed its Cannasphere JV licensing agreement, focusing on data, research, and formulations addressing symptoms related to glaucoma and gastrointestinal issues.

Cannasphere Biotech, LLC, an Arizona-based developer and manufacturer of water-soluble, nanoliposomal cannabinoid products plays a key role in this strategic partnership. Strainsforpains equipped with its database of cannabis cultivars and strain varietals, is well positioned to leverage Cannsphere’s proprietary intellectual property, cannabis experience, and industry relationships, aiming to establish a global presence in the expanding cannabis and CBD markets. As part of this collaboration, the company anticipates a substantial revenue boost of up to $300,000 in fiscal 2024, with all triggers met.

Mr. Shainberg, the president of the company emphasized, “the synergy created by combining the resources of both companies will enhance growth potential and provide Strainsforpains’ products with an additional competitive advantage”. “Furthermore, Strainsforpains has identified other illness and their associated symptoms paving the way for the expansion of the company’s product line.

In tandem with these developments, Strainsforpains’ Pennsylvania facility is undergoing continuous upgrades to facilitate the expansion of manufacturing and distribution capabilities for its growing product line, alongside exploring lease options. The company remains committed to innovation and growth in the dynamic cannabis and pain management industry.

Overview of Strainsforpains, Inc.: Strainsforpains, Inc. is an innovative healthcare data technology Company located in New York, N.Y. The Company's objectives are to provide doctors, nurses, dispensaries, and patients access to an APP that will allow for an advanced determination of comparison of strains or brands of cannabis combinations with major illnesses, in a user-friendly manner. The company owns a 6.5acre facility in Pennsylvania that will be used for CBD product production.

Safe Harbor Statement: Statements in this press release that are not historical fact may be deemed forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Although Strainsforpains, Inc. believes the expectations reflected in any forward-looking statements are based on reasonable assumptions, Strainsforpains, Inc. is unable to give any assurance that its expectations will be attained. Investors are cautioned that any such forward looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond Strainsforpains, Inc.'s ability to control, and those actual results may differ materially from those projected in the forward-looking statements as a result of various factors. More information about the potential factors that could affect the business and financial results is and will be included in Strainsforpains, Inc. filings with the Securities and Exchange Commission and OTC Markets. For further info and Media Contact: Y. S. Shainberg, Strainsforpains, Inc. simon ( @ ) strainsforpains dot com, 347-218-0844. Sean Goodwin: 10kstrains ( @ ) gmail dot com

###

space

Other Related Press Releases